A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to demonstrate the bioequivalence of CJ30001(fixed-dose
combination tablet of HKB0701 and SLM0807) relative to HKB0701 and SLM0807 co-administered to
healthy subjects.